|
Delayed
Toronto S.E.
13:16:29 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 2.650 CAD | +0.76% |
|
-1.49% | +132.46% |
| 09-09 | Medicure Presents Mend-Pnpo Phase 3 Study Design and Baseline Data At the 16Th European Epilepsy Congress | CI |
| 08-17 | Medicure Inc., Q2 2026 Earnings Call, Aug 17, 2026 |
Company Valuation: Medicure Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 12.44 | 9.431 | 10.35 | 14.61 | 9.184 | 11.9 |
| Change | - | -24.17% | 9.78% | 41.12% | -37.14% | 29.55% |
| Enterprise Value (EV) 1 | 11.17 | 6.906 | 6.346 | 8.786 | 2.867 | 8.953 |
| Change | - | -38.16% | -8.11% | 38.45% | -67.37% | 212.3% |
| P/E | -1.86x | -13x | 7.71x | -15.6x | -8.8x | -1.68x |
| PBR | 0.64x | 0.51x | 0.49x | 0.73x | 0.44x | 0.92x |
| PEG | - | 0.1x | -0x | 0x | -0.8x | -0x |
| Capitalization / Revenue | 1.07x | 0.43x | 0.45x | 0.67x | 0.42x | 0.41x |
| EV / Revenue | 0.96x | 0.32x | 0.28x | 0.4x | 0.13x | 0.31x |
| EV / EBITDA | -2.18x | 19.1x | 2.21x | 9.42x | -2.83x | -1.77x |
| EV / EBIT | -1.45x | -2.77x | 5.32x | -10.3x | -1.05x | -1.3x |
| EV / FCF | 2.66x | 6.01x | 4.87x | 3.73x | 5x | 4.07x |
| FCF Yield | 37.6% | 16.6% | 20.5% | 26.8% | 20% | 24.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.6406 | -0.0709 | 0.131 | -0.09 | -0.1 | -0.68 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 11.61 | 21.74 | 23.06 | 21.69 | 21.91 | 28.86 |
| EBITDA 1 | -5.132 | 0.361 | 2.873 | 0.933 | -1.014 | -5.06 |
| EBIT 1 | -7.686 | -2.495 | 1.193 | -0.854 | -2.737 | -6.888 |
| Net income 1 | -6.845 | -0.727 | 1.365 | -0.922 | -1.039 | -7.097 |
| Net Debt 1 | -1.269 | -2.525 | -4.008 | -5.825 | -6.317 | -2.944 |
| Reference price 2 | 1.190 | 0.920 | 1.010 | 1.400 | 0.880 | 1.140 |
| Nbr of stocks (in thousands) | 10,451 | 10,251 | 10,251 | 10,436 | 10,436 | 10,436 |
| Announcement Date | 4/20/21 | 4/27/22 | 4/6/23 | 4/8/24 | 4/25/25 | 4/23/26 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 19.55M | |
| 21.09x | 7.5x | 15.07x | 1.41% | 71.94B | |
| 30.84x | 8.88x | 27.67x | 0.04% | 59.35B | |
| 31.46x | 6.7x | 17.4x | -.--% | 27.16B | |
| -74.58x | 14.32x | -78x | -.--% | 26.54B | |
| -15.32x | 5.85x | -7.35x | -.--% | 24.93B | |
| 28.35x | 5.34x | 17.75x | -.--% | 20.61B | |
| 43.56x | 15.96x | 32.38x | 0.35% | 15.03B | |
| 1013.62x | 35.48x | 612.89x | -.--% | 14.2B | |
| 17.9x | 5.33x | 12.45x | -.--% | 14.36B | |
| Average | 121.88x | 11.71x | 72.25x | 0.2% | 27.42B | |
| Weighted average by Cap. | 64.68x | 9.87x | 38.96x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MPH Stock
- Valuation Medicure Inc.
Select your edition
All financial news and data tailored to specific country editions
